News
Spain is moving forward with plans to extend smoking bans to public spaces, including restaurant terraces and outdoor areas in bars, the southern European country's health minister announced on ...
Jerusalem Post Opinion Spain should think thrice before it lectures Israel about genocide - opinion Spain's historical relationship with the Jews makes its accusations of genocide hypocritical. By ...
Lonza, GBCC launch biomanufacturing apprenticeship PORTSMOUTH — ApprenticeshipNH, the workforce training program of the Community College System of New Hampshire, has partnered with Lonza to ...
Going to the valuation, considering the latest acquisition, Lonza's net debt moved to CHF 4 billion, and applying an unchanged EV/EBITDA of 21x (aligned with its 5-year historical average), in our ...
Lonza Group AG / Key word (s): Miscellaneous Lonza Implements its Simplified and Streamlined Operating Model 01.04.2025 / 14:00 CET/CEST Lonza’s new simplified and streamlined operating model is ...
Lonza’s 8,200 square foot expansion “will be used for high-density employee seating, office space, additional conference rooms and an expanded cafeteria,” Mates said.
Swiss Biotechnology firm Lonza, which purchased the Genentech facility in Vacaville last year, reported an income of 6.6 billion in Swiss francs (CHF) for the year 2024, which converts to about $7.… ...
Reflecting on 2024, Wienand reported that Lonza’s organic growth rate was 2–3% ahead of the market, with a mid-to-high teens capital expenditure in percentage of sales over time.
In other recent news, Lonza Group AG has been the center of several significant developments. The company reported a 1.8% sales increase to CHF 3.1 billion in its H1 2024 earnings call, along with ...
Lonza announced at an investor event that it plans to divest its Capsules and Health Ingredients (CHI) business. Although the segment is profitable, it no longer fits with Lonza’s core business ...
Genentech said Lonza Group Ltd. will purchase Genentech's manufacturing facility in Porriño, Spain, for $150 million. Genentech will also enter into a supply agreement to manufacture certain Genentech ...
Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of An
Lonza Group AG / Key word (s): Partnership/Agreement Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates 22.10.2024 / 07:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results